AstraZeneca and Oxford University acknowledged on Wednesday that a manufacturing error has cast doubt on their recent announcement that their COVID-19 vaccine candidate was up to 90% effective.

The Monday announcement claimed that partial results from larger studies showed AstraZeneca’s vaccine had an average 70% effectiveness based on evidence that one dosage amount was roughly 90% effective and another was 62% effective.

Recommended Stories

Biden administration sending India materials for millions of AstraZeneca vaccines

Coronavirus vaccine development at ‘warp speed pace,’ officials say

Pfizer-BioNTech asks FDA to authorize COVID-19 vaccine for children under 5